Redx appoints Lisa Anson as new Chief Executive OfficerRedx Pharma announced today that it has appointed Lisa Anson as Chief Executive Officer (CEO) and to its Board of Directors. Lisa will take up both roles on 1 June 2018. At that time Iain Ross, currently … more ➔
Sanofi names John Reed as new Head of Global R&DElias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the … more ➔
Sanofi names John Reed as new Head of Global R&DElias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the … more ➔
Abivax appoints Alexandra Pearce as VP of Regulatory AffairsDr. Pearce Joins as ABIVAX Works with FDA and EMA on Next Stage Developments of its Clinical Product Candidates more ➔
Commense Appoints Edward J. Stewart as President and CEOCommense, Inc., an affiliate of PureTech Health plc developing microbiome-derived immune modulators for paediatric and maternal health, today announced the appointment of Edward J. Tad Stewart as President … more ➔
Nordic Nanovector’s Luigi Costa to step down as CEONordic Nanovector ASA announces that Luigi Costa will step down as Chief Executive Officer by mutual agreement with the Board of Directors. A search for a new CEO will begin immediately. To ensure a … more ➔
Namal Nawana appointed CEO of Smith & NephewSmith & Nephew plc today announced the appointment of Namal Nawana as Chief Executive Officer. He will join the Company and be appointed to the Board as an Executive Director on 7 May 2018. more ➔
Abeona Therapeutics Appoints Carsten Thiel as CEOAbeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of … more ➔
Rentschler appoints Dr. Thomas RöschRentschler Biopharma SE announced today that Dr. Thomas Rösch will join the Company as Vice President Biopharma Engineering & Technology, effective April 1, 2018. He will be responsible for advanced … more ➔
Søren Tulstrup appointed CEO of Hansa MedicalHansa Medical AB, a biopharmaceutical company developing novel immunomodulatory enzymes, today announced that the board of directors have appointed Søren Tulstrup as new President and CEO of Hansa Medical … more ➔
